» Articles » PMID: 29034188

Validation of Therapeutic Anti-inflammatory Potential of - A Traditional Formulation of

Overview
Date 2017 Oct 17
PMID 29034188
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

(AKP), a traditional formulation of (. ) bark powder is used for its cardioprotective effects. However, its anti-inflammatory efficacy remained unexplored. In the present study, AKP was prepared in cow milk (as per standard procedure) and compared with standard hydroalcoholic extract (HA) of . . The extracts were analyzed for gross phytoconstituents levels, and their antioxidant activity was assayed by DPPH free radical scavenging activity and inhibition of lipid peroxidation. The anti-inflammatory activity of AKP and HA was studied in carrageenan-induced hind paw biphasic edema in C57BL/6 mice (at 200, 400 and 800 mg/kg BW). The percentage extraction yield of AKP was two folds higher than HA implying that the phytoconstituents in AKP were diluted by a factor of 0.5. The total polyphenol content of HA was (3.8 times) higher than AKP and the antioxidant activity of HA was also higher compared to AKP. Both the extracts, however, showed significant (p < 0.05) anti-inflammatory activity in reducing paw edema in mice. The efficacy of HA was more than AKP at early phase of inflammation, whereas, in the late phase of inflammation AKP was more efficacious and equipotent to HA. Thus, regardless of low antioxidant activity, AKP exhibited potential anti-inflammatory activity. The higher efficacy of AKP could be due to the presence of milk solids. These milk solids may act as adjuvants to 's phytoconstituents, contributing to their sustained bioavailability, leading to higher anti-inflammatory efficacy at lower drug concentrations.

Citing Articles

Neuroprotective Properties of Oleanolic Acid-Computational-Driven Molecular Research Combined with In Vitro and In Vivo Experiments.

Stepnik K, Kukula-Koch W, Plazinski W, Rybicka M, Gawel K Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765042 PMC: 10536188. DOI: 10.3390/ph16091234.


Molecular and Pharmacokinetic Aspects of the Acetylcholinesterase-Inhibitory Potential of the Oleanane-Type Triterpenes and Their Glycosides.

Stepnik K, Kukula-Koch W, Plazinski W Biomolecules. 2023; 13(9).

PMID: 37759757 PMC: 10526139. DOI: 10.3390/biom13091357.


, a Cardioprotective Herbal Medicine-Relevancy in the Modern Era of Pharmaceuticals and Green Nanomedicine-A Review.

Ramesh P, Palaniappan A Pharmaceuticals (Basel). 2023; 16(1).

PMID: 36678623 PMC: 9865560. DOI: 10.3390/ph16010126.


Biomimetic Chromatographic Studies Combined with the Computational Approach to Investigate the Ability of Triterpenoid Saponins of Plant Origin to Cross the Blood-Brain Barrier.

Stepnik K Int J Mol Sci. 2021; 22(7).

PMID: 33808219 PMC: 8037809. DOI: 10.3390/ijms22073573.


Protective effect of Terminalia arjuna against alcohol induced oxidative damage of rat erythrocyte membranes.

Hebbani A, Vaddi D, Dd P, NCh V J Ayurveda Integr Med. 2021; 12(2):330-339.

PMID: 33731264 PMC: 8186002. DOI: 10.1016/j.jaim.2021.02.001.

References
1.
Elzoghby A, El-Fotoh W, Elgindy N . Casein-based formulations as promising controlled release drug delivery systems. J Control Release. 2011; 153(3):206-16. DOI: 10.1016/j.jconrel.2011.02.010. View

2.
Haug A, Hostmark A, Harstad O . Bovine milk in human nutrition--a review. Lipids Health Dis. 2007; 6:25. PMC: 2039733. DOI: 10.1186/1476-511X-6-25. View

3.
Ram A, Lauria P, Gupta R, Kumar P, Sharma V . Hypocholesterolaemic effects of Terminalia arjuna tree bark. J Ethnopharmacol. 1997; 55(3):165-9. DOI: 10.1016/s0378-8741(96)01493-6. View

4.
Henriques M, Silva P, Martins M, Flores C, Cunha F, Cordeiro R . Mouse paw edema. A new model for inflammation?. Braz J Med Biol Res. 1987; 20(2):243-9. View

5.
Arts M, Haenen G, Wilms L, Beetstra S, Heijnen C, Voss H . Interactions between flavonoids and proteins: effect on the total antioxidant capacity. J Agric Food Chem. 2002; 50(5):1184-7. DOI: 10.1021/jf010855a. View